Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gabay Avraham
Oramed Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Gabay Avraham
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Reznick Yehuda
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Reznick Yehuda
Oramed Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Reznick Yehuda
Oramed Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Nadav Kidron(5.7%)
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aghion Daniel
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kidron Miriam
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KIDRON NADAV
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hexter Joshua
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mayer Arie
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Rozov Yadin
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sank Leonard
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Silberman David
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shapiro Benjamin
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aghion Daniel
Oramed Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Aghion Daniel
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KIDRON NADAV
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kidron Miriam
Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Derovan Netanel
No Data